BTC $63,930.18 -2.14%
ETH $1,853.85 -1.82%
BNB $564.49 -0.63%
XRP $1.08 -2.27%
SOL $73.76 -2.69%
TRX $0.3292 -0.52%
DOGE $0.0693 -0.73%
ADA $0.1617 -3.43%
BCH $210.44 -0.65%
LINK $8.27 -2.66%
HYPE $57.20 -2.97%
AAVE $91.20 -4.91%
SUI $0.7050 -4.95%
XLM $0.1772 -3.49%
ZEC $475.43 -6.77%
BTC $63,930.18 -2.14%
ETH $1,853.85 -1.82%
BNB $564.49 -0.63%
XRP $1.08 -2.27%
SOL $73.76 -2.69%
TRX $0.3292 -0.52%
DOGE $0.0693 -0.73%
ADA $0.1617 -3.43%
BCH $210.44 -0.65%
LINK $8.27 -2.66%
HYPE $57.20 -2.97%
AAVE $91.20 -4.91%
SUI $0.7050 -4.95%
XLM $0.1772 -3.49%
ZEC $475.43 -6.77%

Public company Leap Therapeutics completes $58,888,888 private placement to initiate digital asset financial strategy

2025-10-09 19:13:53
Collection

ChainCatcher news, biotechnology company Leap Therapeutics (NASDAQ: LPTX) announced that it has completed the previously announced private placement led by Winklevoss Capital, raising $58,888,888 in cash to initiate its digital asset financial strategy.

Winklevoss Capital will provide funding and strategic support to help Leap build and execute its digital asset financial strategy.

app_icon
ChainCatcher Building the Web3 world with innovations.